日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Measuring teachers' readiness to use ICT before the COVID-19 pandemic in Italy

在意大利新冠疫情爆发前,评估教师使用信息通信技术的准备情况

D'Agostino, Antonella; Longobardi, Sergio; Migali, Giuseppe; Russo, Felice

The European Medicines Agency review of entrectinib for the treatment of adult or paediatric patients with solid tumours who have a neurotrophic tyrosine receptor kinase gene fusions and adult patients with non-small-cell lung cancer harbouring ROS1 rearrangements

欧洲药品管理局对恩曲替尼用于治疗携带神经营养酪氨酸受体激酶基因融合的成人或儿童实体瘤患者以及携带ROS1重排的非小细胞肺癌成人患者的审查

Delgado, J; Pean, E; Melchiorri, D; Migali, C; Josephson, F; Enzmann, H; Pignatti, F

The EMA assessment of pembrolizumab as monotherapy for the first-line treatment of adult patients with metastatic microsatellite instability-high or mismatch repair deficient colorectal cancer

EMA对帕博利珠单抗作为一线单药疗法治疗转移性微卫星不稳定性高或错配修复缺陷型结直肠癌成年患者的评估

Trullas, A; Delgado, J; Genazzani, A; Mueller-Berghaus, J; Migali, C; Müller-Egert, S; Zander, H; Enzmann, H; Pignatti, F

Luminal Breast Cancer: Risk of Recurrence and Tumor-Associated Immune Suppression

管腔型乳腺癌:复发风险和肿瘤相关免疫抑制

Pellegrino, Benedetta; Hlavata, Zuzana; Migali, Cristina; De Silva, Pushpamali; Aiello, Marco; Willard-Gallo, Karen; Musolino, Antonino; Solinas, Cinzia

Albumin losses during hemodiafiltration: all dialyzers are not created equal - a case report

血液透析滤过过程中白蛋白丢失:并非所有透析器都一样——病例报告

Cuvelier, Charles; Tintillier, Michel; Migali, Gabriela; Van Ende, Charlotte; Pochet, Jean-Michel

Biologics and biosimilars: what, why and how?

生物制剂和生物类似药:是什么、为什么以及如何使用?

Dolly, Saoirse O; Migali, Cristina; Tunariu, Nina; Della-Pepa, Chiara; Khakoo, Shelize; Hazell, Steve; de Bono, Johann S; Kaye, Stanley B; Banerjee, Susana; Chan, Juliana CN; Chan, Anthony TC

Strategies to modulate the immune system in breast cancer: checkpoint inhibitors and beyond

乳腺癌免疫系统调控策略:检查点抑制剂及其他

Migali, Cristina; Milano, Monica; Trapani, Dario; Criscitiello, Carmen; Esposito, Angela; Locatelli, Marzia; Minchella, Ida; Curigliano, Giuseppe

Regulatory (FoxP3+) T-cell tumor infiltration is a favorable prognostic factor in advanced colon cancer patients undergoing chemo or chemoimmunotherapy

调节性(FoxP3+)T细胞肿瘤浸润是接受化疗或化疗免疫疗法的晚期结肠癌患者的有利预后因素。

Correale, Pierpaolo; Rotundo, Maria Saveria; Del Vecchio, Maria Teresa; Remondo, Cinzia; Migali, Cristina; Ginanneschi, Chiara; Tsang, Kwong Y; Licchetta, Antonella; Mannucci, Susanna; Loiacono, Lucia; Tassone, Pierfrancesco; Francini, Guido; Tagliaferri, Pierosandro

Interest of PET-scan in the management of severe hyperparathyroidism

PET扫描在重度甲状旁腺功能亢进症管理中的意义

Migali, Gabriela; Lecouvet, Frederic; Lonneux, Max; Goffin, Eric

Interaction between estradiol and tacrolimus in kidney-transplanted menopausal women

肾移植绝经期妇女雌二醇与他克莫司的相互作用

Migali, Gabriela; Tintillier, Michel